Julia Elvin
7PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 04, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.Nicolas Sayegh, Ryon P Graf, Umang Swami
|Jul 30, 2024
Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice.Debra L Richardson, Julia C F Quintanilha, Natalie Danziger
|Nov 29, 2022
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit.Daniel F Hayes, Roy S Herbst, Jonathan L Myles
|Nov 21, 2020
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.Jeffrey S Ross, Ethan S Sokol, Holger Moch
|Mar 16, 2018
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing.James H Suh, Alexa B Schrock, Adrienne Johnson
Pageof 2
Frequent Collaborators
3 joint publications
Gerald Li
3 joint publications
Jeffrey S Ross
3 joint publications
Ryon P Graf
2 joint publications
Alexa B Schrock
2 joint publications
Julia C F Quintanilha
2 joint publications
Natalie Danziger
2 joint publications
Douglas Lin
1 joint publications
James H Suh
1 joint publications
James Hadfield
1 joint publications
Vincent A Miller